Imricor Medical Systems
Burnsville, US · Delaware corporation
Imricor develops MRI-guided cardiac electrophysiology products, including the Vision-MR ablation and diagnostic catheters, the NorthStar Mapping System, and the Advantage-MR EP Recorder/Stimulator, used to perform catheter ablation procedures under real-time MRI. The company's devices are targeted at cardiac electrophysiology labs, with several products holding CE mark and some FDA clearance.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$3.7M disclosed across 3 rounds · 2017–2019
▶$613.1KraisedSep 2019 · 12 investors · Other Health CareRule 506(b)
- Lori MilbrandtExecutive Officer
- Steve WedanExecutive Officer, Director
- Doris EngibousDirector
- Mark TibblesDirector
- Peter McGregorDirector
- Offering amount
- $613.1K
- Amount sold
- $613.1K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMay 2018 · 19 investors · Other Health CareRule 506(b)
- Mark TibblesDirector
- Steven WedanExecutive Officer, Director
- Lori MilbrandtExecutive Officer
- Niels KusterDirector
- Tom BorilloDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedSep 2017 · 15 investors · Other Health CareRule 506(b)
- Steven R. WedanExecutive Officer, Director
- Mark TibblesDirector
- Niels KusterDirector
- Thomas BorilloDirector
- Offering amount
- $3M
- Amount sold
- $1.6M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Imricor Medical Systems for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $399.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2008 | $919.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Imricor Medical Systems do?
- Imricor develops MRI-guided cardiac electrophysiology products, including the Vision-MR ablation and diagnostic catheters, the NorthStar Mapping System, and the Advantage-MR EP Recorder/Stimulator, used to perform catheter ablation procedures under real-time MRI. The company's devices are targeted at cardiac electrophysiology labs, with several products holding CE mark and some FDA clearance.
- Who founded Imricor Medical Systems?
- Imricor Medical Systems was founded by Steven R. Wedan.
- How much funding has Imricor Medical Systems raised?
- Imricor Medical Systems has disclosed $3.7M raised across 3 rounds.
- Where is Imricor Medical Systems headquartered?
- Imricor Medical Systems is headquartered in Burnsville, US.